A detailed history of Norwood Financial Corp transactions in Organon & Co. stock. As of the latest transaction made, Norwood Financial Corp holds 261 shares of OGN stock, worth $3,807. This represents 0.01% of its overall portfolio holdings.

Number of Shares
261
Previous 369 29.27%
Holding current value
$3,807
Previous $5,000 20.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$13.78 - $18.8 $1,488 - $2,030
-108 Reduced 29.27%
261 $4,000
Q4 2023

Jan 11, 2024

SELL
$10.95 - $17.32 $273 - $433
-25 Reduced 6.35%
369 $5,000
Q3 2023

Oct 16, 2023

SELL
$16.59 - $23.77 $165 - $237
-10 Reduced 2.48%
394 $6,000
Q4 2022

Jan 13, 2023

SELL
$23.31 - $28.61 $233 - $286
-10 Reduced 2.42%
404 $0
Q4 2021

Feb 08, 2022

BUY
$28.67 - $37.13 $11,869 - $15,371
414 New
414 $12,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.